摘要
对500多例（20564人次）多种疾病的患者应用窄谱中波紫外线（简称NB-UVB）进行治疗并获得成功。NB-UVB由最初治疗银屑病,逐渐发展到治疗白癜风、异位性皮炎、瘙痒症、多形性日光症以及早期的皮肤T细胞淋巴瘤等皮肤病中,具有较好的前景。通过大量的临床观察,发现波长为311nm窄谱中波紫外线（narrowbandultraviolet B,NB-UVB）是最具有治疗作用的成分。经加强安全护理均顺利完成治疗。NB-UVB临床有效率均在70%~80%,未发生NB-UVB治疗严重并发症及差错事故,提示强化治疗前、中、后安全护理的重要性。
Patients with a variety of diseases in over 500 cases（20564 people）have been treated with narrow-band ultraviolet B radiation（referred to as NB-UVB）and cured.NB-UVB,firstly used to treat psoriasis,has been gradually developed into the treatment of vitiligo,atopic dermatitis,pruritus,polymorphous light eruption,early cutaneous T-cell lymphoma and other skin diseases,which has showed good prospects.Through a large number of clinical observations,we find when NB-UVB＇s wavelength is 311nm,it has the biggest therapeutic effect.All of the treatments can be successfully completed with safety nursing.NB-UVB clinical effective rate is 70%~80%,no severe complications and errors are found after NB-UVB treatment,which suggests enhancing safety nursing along the whole process of treatment is very important.
出处
《辽宁中医药大学学报》
CAS
2012年第12期165-167,共3页
Journal of Liaoning University of Traditional Chinese Medicine
作者简介
秦锐（1964-），女，江苏南京人，主管护师，研究方向：皮肤科护理
